Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active Intralymphatic Immunotherapy with Tumor Cell Vaccine in Advanced Cancer
NCT00002475Phase 2Completed
- Sponsor
- St. Vincent Medical Center
- Start
- Apr 1991
- Primary completion
- Dec 2007
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Tumor Cell Vaccine-Hadassah Medical Organization-solid tumors in breast cancer, colorectal cancer (CRC), kidney cancer and 3 more, sponsored by St. Vincent Medical Center. Primary endpoints: Clinical response, Duration of response and 2 more. Started Apr 1991; status: completed.
02
Drugs
Tumor Cell Vaccine-Hadassah Medical Organization-solid tumors
03
Conditions
breast cancercolorectal cancer (CRC)kidney cancerlung cancermalignant mesothelioma
Beyond the preview
Go deeper on NCT00002475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002475.